Zentek Ltd. (NASDAQ:ZTEK) | WebDisclosure

Basculer en Français

8302	Companies
115125	Keywords
55448	Articles
62531	Press releases

Home
Companies
Zentek Ltd.

BRIEF

published on 04/03/2024 at 14:30, 7 months 18 days ago

Zentek s'associe à Medwell Solutions pour la distribution des masques chirurgicaux améliorés ZenGUARD™ aux États-Unis

Zentek Ltd. Approbation De La FDA Solutions Medwell Masques Chirurgicaux Améliorés ZenGUARD Distribution De Soins De Santé
PRESS RELEASE

published on 04/03/2024 at 14:25, 7 months 18 days ago

Zentek Announces U.S. Distribution Agreement for ZenGUARDTM-Enhanced Surgical Masks with Medwell Solutions
Zentek Ltd. announces definitive distribution agreement with Medwell Solutions LLC for ZenGUARDTM Enhanced Surgical Masks in the U.S. to cater to healthcare demand

Distribution Agreement Healthcare Zentek Ltd. ZenGUARD Enhanced Surgical Masks Medwell Solutions LLC
BRIEF

published on 03/25/2024 at 13:05, 7 months 27 days ago

Zentek Ltd. annonce des résultats précliniques prometteurs pour l'aptamère C19HBA

Zentek Ltd. Triera Biosciences C19HBA SRAS-CoV-2 Technologie Aptamère
BRIEF

published on 03/25/2024 at 13:05, 7 months 27 days ago

Zentek Ltd. Reports Promising Preclinical Results for C19HBA Aptamer

Triera Biosciences Zentek Ltd C19HBA SARS-CoV-2 Aptamer Technology
PRESS RELEASE

published on 03/25/2024 at 13:00, 7 months 27 days ago

Zentek Announces Promising Preclinical Safety and Toxicity Results achieved by Triera Biosciences Ltd. for C19HBA
Zentek Ltd. announces successful safety and toxicity testing of C19HBA SARS-CoV-2 universal aptamer in preclinical trials, showing promising results for future human therapeutics

Zentek Ltd. C19HBA SARS-CoV-2 Preclinical Testing Aptamer Platform
PRESS RELEASE

published on 01/30/2024 at 14:13, 9 months 22 days ago

Zentek Announces Positive Therapeutic Results achieved by Triera Biosciences for C19HBA
Zentek Ltd.'s subsidiary Triera Biosciences completes successful testing of C19HBA aptamer as therapeutic for SARS-CoV-2, outperforming monoclonal antibody in preclinical trials. C19HBA shows potential for prophylaxis and treatment. Future clinical trials and partnerships to be pursued

Zentek Ltd. Triera Biosciences C19HBA Aptamer SARS-CoV-2 Therapeutic Preclinical Trials
PRESS RELEASE

published on 01/22/2024 at 16:00, 9 months 30 days ago

Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters
Zentek Ltd. announces the completion of a new study showing significant energy and cost savings for commercial buildings adopting ZenGUARDTM Enhanced Air Filters. The study highlights the reduction of infection risk and the potential to reduce HVAC energy consumption and CO2 emissions. Find out more on Zentek's website.

Zentek Ltd. ZenGUARDTM Enhanced Air Filters HVAC Energy Consumption CO2 Emissions Commercial Buildings
PRESS RELEASE

published on 01/19/2024 at 14:45, 10 months 2 days ago

Zentek Announces Eric Wallman Appointed as Chairman of the Board
Zentek Ltd., an intellectual property development and commercialization company, announces the resignation of Dr. Francis Dubé as Chairman of the Board and the appointment of Mr. Eric Wallman as the new Chairman according to best practices in governance. The company continues to focus on research, development, and commercialization of novel products, including their patented technology platform, ZenGUARD™, known for its anti-microbial activity and increased filtration efficiency.

Zentek Ltd. Intellectual Property Development Governance Best Practices ZenGUARD Technology Commercialization Company
PRESS RELEASE

published on 12/13/2023 at 21:30, 11 months 8 days ago

Zentek Launches Triera Biosciences Ltd.
PRESS RELEASE

published on 12/08/2023 at 14:15, 11 months 13 days ago

Zentek and 1Click Heating and Cooling Sign Distribution Agreement

Accesswire

Published on 11/22/2024 at 00:00, 59 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 2 hours 54 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 3 hours 9 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 4 hours 44 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 4 hours 49 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 5 hours 57 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 6 hours 22 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 7 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 7 hours 7 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 7 hours 7 minutes ago

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.

Les Echos

Published on 11/21/2024 at 06:58, 18 hours 1 minute ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 18 hours 1 minute ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 18 hours 1 minute ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 4 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 5 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE